UniProt ID ▼ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
B1AS16 | Membrane metallo-endopeptidase-like 1 |
|
2 | 0 |
|
B1AS15 | Membrane metallo-endopeptidase-like 1 |
|
2 | 0 |
|
B1ARJ2 | Intercellular adhesion molecule 2 (Fragment) |
|
2 | 0 |
|
B1ARB3 | Platelet/endothelial cell adhesion molecule 1 |
|
7 | 0 |
|
B1ARA9 | Platelet/endothelial cell adhesion molecule 1 (Fragment) |
|
3 | 0 |
|
B1ARA5 | Large ribosomal subunit protein uL24 |
|
1 | 0 |
|
B1ARA3 | Large ribosomal subunit protein uL24 (Fragment) |
|
1 | 1 |
|
B1AR93 | PAT complex subunit CCDC47 (Fragment) |
|
0 | 1 |
|
B1AR69 | Myosin, heavy polypeptide 13, skeletal muscle |
|
1 | 0 |
|
B1AR35 | Asialoglycoprotein receptor 2 (Fragment) |
|
1 | 0 |
|
B1AR34 | Asialoglycoprotein receptor 1 |
|
2 | 0 |
|
B1AR28 | Very long-chain specific acyl-CoA dehydrogenase, mitochondrial |
|
0 | 1 |
|
B1AR13 | CDGSH iron-sulfur domain-containing protein 3, mitochondrial |
|
0 | 1 |
|
B1AR10 | Myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6 |
|
0 | 1 |
|
B1AR09 | Myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6 |
|
0 | 1 |
|
B1AQX6 | SRC kinase signaling inhibitor 1 |
|
0 | 1 |
|
B1AQW2 | Microtubule-associated protein |
|
1 | 0 |
|
B1AQN2 | protein-tyrosine-phosphatase |
|
1 | 0 |
|
B1AQJ2 | Ubiquitin carboxyl-terminal hydrolase 36 |
|
0 | 1 |
|
B0V2N8 | Annexin (Fragment) |
|
0 | 1 |
|
B0V2N1 | Receptor-type tyrosine-protein phosphatase S |
|
4 | 5 |
|
B0R0N4 | Solute carrier family 43, member 1 (Fragment) |
|
2 | 0 |
|
B0QZX1 | Interleukin 2 receptor, gamma chain (Fragment) |
|
2 | 0 |
|
B0QZW1 | Glutamate receptor |
|
4 | 0 |
|
B0QZJ0 | Tumor necrosis factor (ligand) superfamily, membrane-bound member 13 |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024